Drug Manufacturers are Blaming Others for Prices… Again
Over the past half decade, as public outrage over increasing prescription drug costs has grown, brand pharmaceutical manufacturers have undertaken a massive campaign to deflect blame for their pricing decisions.
Ironically, the industry that controls the list price of prescription drugs has attempted to point the finger at those focused on reducing the cost of prescription drugs for patients and payers.
We hope negotiators continue to resist the latest attempts to shift the blame and put profits over patients.
- See study by Visante Consulting that examines the strategies brand pharmaceutical manufacturers use to maintain high prices.
- Click here to see a new infographic, “PCMA Supports Straightforward Solutions to Reduce Drug Costs.”
- Multiple solutions that will work for taxpayers and patients. The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access.